Aera was founded with a vision to unlock the potential of genetic medicines across a broad range of modalities and therapeutic areas. Our protein nanoparticle (PNP) delivery platform leverages the discovery of endogenous, human proteins that can self-assemble to form capsid-like structures and that can package and transfer nucleic acid cargo. This platform has the potential to address many of the limitations of today’s delivery technologies and to enable various genetic medicine modalities.
Company Details
- Employees
- 85
- Address
- Boston, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://aeratx.com
- Keywords
- spanning R&D.
- HQ
- Boston, MA
Aera Therapeutics Questions
Aera Therapeutics's website is https://aeratx.com
Aera Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aera-therapeutics
Aera Therapeutics has
85 employees.
View email and phone details for 85
employees at Aera Therapeutics.
Aera Therapeutics's industry is
Biotechnology Research
Aera Therapeutics's top competitors are
Renagade Therapeutics,
Entrada Therapeutics,
Orna Therapeutics,
Tessera Therapeutics,
Verve Therapeutics,
Rapport Therapeutics,
Beam Therapeutics,
Kymera Therapeutics,
Orbital Therapeutics,
Nvelop Therapeutics.
Aera Therapeutics's categories are Biotechnology Research
